Pharmaron Beijing Co., Ltd.

SZSE:300759.SZ

27.61 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q4
Revenue 3,098.8143,458.53,212.8122,904.2252,641.0892,953.9012,920.1392,916.1472,723.9712,863.4942,768.2092,531.6862,102.92,142.2372,016.0221,796.1261,489.3851,547.6291,392.8011,233.983959.1841,130.673989.974873.196763.317872.62764.93688.423582.15677.649
Cost of Revenue 2,055.9012,241.7742,097.5851,999.4231,798.5921,992.0271,891.3311,842.0171,749.0051,800.0891,689.7631,604.6831,407.2721,401.8641,270.4541,120.469972.067977.619837.871756.362638.223678.663632.399599.535512.186575.469512.729502.348386.212473.331
Gross Profit 1,042.9131,216.7261,115.227904.802842.497961.8731,028.8081,074.13974.9661,063.4051,078.445927.003695.628740.373745.568675.657517.318570.01554.93477.621320.961452.011357.574273.66251.131297.151252.202186.075195.938204.318
Gross Profit Ratio 0.3370.3520.3470.3120.3190.3260.3520.3680.3580.3710.390.3660.3310.3460.370.3760.3470.3680.3980.3870.3350.40.3610.3130.3290.3410.330.270.3370.302
Reseach & Development Expenses 122.211137.007124.455105.34893.606144.007114.585105.3476.839104.85693.79944.02239.64741.92345.38835.36929.09536.29825.94322.15520.94919.89916.28517.9948.6938.0848.9738.0836.4715.456
General & Administrative Expenses 396.944-530.383842.784-34.942398.608-461.843819.17-19.57414.376461.543741.44.346290.52-343.525499.686-89.702188.365-150.995158.364-9.101141.864-124.017121.129-41.707116.316-146.398100.815-19.9484.256-111.59
Selling & Marketing Expenses 68.848-142.123164.40667.48255.46858.8667.14271.0855.69767.03154.9361.28546.82451.23540.64831.6732.06327.41524.80622.5317.89226.61517.60716.01212.75420.34210.9913.3510.06817.375
SG&A 465.792-672.506468.665433.015460.291412.45886.31251.51470.073540.935796.3365.631337.344-292.29540.334-58.032220.428-123.58183.1713.429159.756-97.402138.736-25.694129.07-126.056111.805-6.59194.324-94.215
Other Expenses 91.0381,274.997-414.410.253-0.254-6.47-46.60444.035-1.731-49.275-333.911351.8054.87210.50783.652-86.495-0.60975.568-0.28186.642-4.2611.2765.870.1631.8615.4153.9020.5910.5549.507
Operating Expenses 679.04739.498717.235538.11554.151562.927571.888589.327545.18596.516556.218461.458381.862339.231324.358250.547239.923265.462201.259187.831184.39170.366162.336150.883146.649152.461127.868100.659107.04490.158
Operating Income 363.873477.228397.992366.692288.347398.946414.606482.306431.572466.888373.418428.877320.066708.318536.343386.583283.093426.06361.183417.695118.896263.666185.225120.89961.697112.282124.40496.11446.79785.886
Operating Income Ratio 0.1170.1380.1240.1260.1090.1350.1420.1650.1580.1630.1350.1690.1520.3310.2660.2150.190.2750.2590.3380.1240.2330.1870.1380.0810.1290.1630.140.080.127
Total Other Income Expenses Net -0.286-7.84-2.967-2.59812.688-2.466-2.187-0.382-4.971-7.967-9.289-2.358-3.8860.110.314-3.157-0.6090.108-0.281-0.031-4.261-8.903-0.4422.238-1.059-4.9463.9027.9670.5549.507
Income Before Tax 363.587469.388395.024976.055281.103530.306412.419481.924426.601458.922464.772426.519316.179708.428536.657383.426282.484426.168360.902417.664114.635254.763191.095123.13763.557127.697128.30696.70547.35195.393
Income Before Tax Ratio 0.1170.1360.1230.3360.1060.180.1410.1650.1570.160.1680.1680.150.3310.2660.2130.190.2750.2590.3380.120.2250.1930.1410.0830.1460.1680.140.0810.141
Income Tax Expense 83.932124.436108.76491.20552.69969.68661.96348.00376.45450.96385.89498.17179.22792.2880.02972.79945.81245.40461.3144.20521.45941.54930.31718.76711.24519.16320.00214.5637.71220.08
Net Income 305.575371.552308.396882.845230.558462.058352.945437.838348.255413.497375.675336.346249.087620.966475.227318.962245.874383.339310.083377.442101.518218.811167.056106.92854.396108.596108.06381.33540.82575.534
Net Income Ratio 0.0990.1070.0960.3040.0870.1560.1210.150.1280.1440.1360.1330.1180.290.2360.1780.1650.2480.2230.3060.1060.1940.1690.1220.0710.1240.1410.1180.070.111
EPS 0.170.170.170.50.130.260.30.250.20.230.470.430.210.780.60.40.210.490.260.480.0860.330.170.170.0570.180.120.140.0460.13
EPS Diluted 0.170.170.170.50.130.260.20.250.20.230.470.430.210.780.60.40.210.490.260.480.0860.330.170.170.0570.180.120.140.0460.13
EBITDA 407.463519.684450.1921,043.74471.205841.856720.632765.925702.336514.046508.109585.113533.349742.657569.715516.67423.174550.771422.074535.694200.287374.142248.619145.01786.209206.345206.332127.98262.929160.626
EBITDA Ratio 0.1310.150.140.3590.1780.2850.2470.2630.2580.180.1840.2310.2540.3470.2830.2880.2840.3560.3030.4340.2090.3310.2510.1660.1130.2360.270.1860.1080.237